PT  - JOURNAL ARTICLE
AU  - Moffitt, Michelle
AU  - Bencivenni, Davide
AU  - Cohen, Robert
TI  - Treatment Modalities for Drug–Induced Gingival Enlargement
DP  - 2012 Sep 01
TA  - American Dental Hygienists Association
PG  - 272--277
VI  - 86
IP  - 4
4099  - http://jdh.adha.org/content/86/4/272.short
4100  - http://jdh.adha.org/content/86/4/272.full
SO  - J Dent Hyg2012 Sep 01; 86
AB  - Purpose: This paper identifies 3 specific classifications of commonly prescribed medications that are known to cause gingival enlargement and describes surgical and non-surgical treatment therapies. Primary risks associated with druginduced gingival enlargement, including increased dental decay and periodontal disease are also discussed. The precise bacterial etiology in gingival enlargement remains unclear, although sufficient evidence exists to support the role of good oral hygiene in decreasing the incidence and severity of gingival enlargement and improving overall gingival health. Etiology, treatment planning and coordination of care between physician, dentist or dental hygienist when indicated are important factors determining whether a surgical or non-surgical course of treatment should be considered. This study supports the NDHRA priority area, Health Promotion/Disease Prevention: Validate and test assessment instruments/strategies/mechanisms that increase health promotion and disease prevention among diverse populations.